Food and Drug Administration Accountability and Transparency Act
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the postmarket surveillance of devices.
Other Bill Titles (2 more) 5/15/2008--Introduced.
Food and Drug Administration Accountability and Transparency Act - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services to publish in the Federal Register postmarket surveillance plans for medical devices, unless s... moreSee Full Bill Text
Sponsor
Amendments
This bill has no amendments.
Bill Status
| Introduced | ![]() | Voted on by Senate | ![]() | Voted on by House | ![]() | Considered By President | ![]() | Bill Becomes Law |
| May 15, 2008 |
In the News
We are not currently finding any news articles on this topic using our daily automated search of Google News. However, if you know of a relevant news article to display here, OpenCongress site editors have the ability to add it manually. Simply e-mail us the web address of this page and the web address of your suggested news article: We'll post relevant links as quickly as possible. Also, if this topic is important to you, you could write a letter to the editor -- if a news article refers this specific topic by name, a link to that news article is likely to appear here soon.
Blog Coverage
May 14, 2008 S. 3020, A bill to amend the Federal Food, Drug, and Cosmetic Act ...
S. 3020 would amend the Federal Food, Drug, and Cosmetic Act with respect to the postmarket surveillance of devices.... Vote on This Bill: For | Against.








Rating Filter: 5
(Close help)
Comments
(Close help)
No Comments
Add A Comment